These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 35012577)

  • 1. Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation.
    Dumesic DA; Padmanabhan V; Chazenbalk GD; Abbott DH
    Reprod Biol Endocrinol; 2022 Jan; 20(1):12. PubMed ID: 35012577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Evolutionary Model for the Ancient Origins of Polycystic Ovary Syndrome.
    Dumesic DA; Abbott DH; Chazenbalk GD
    J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine-Metabolic Dysfunction in Polycystic Ovary Syndrome: an Evolutionary Perspective.
    Dumesic DA; Abbott DH; Sanchita S; Chazenbalk GD
    Curr Opin Endocr Metab Res; 2020 Jun; 12():41-48. PubMed ID: 32363240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome.
    Dumesic DA; Tulberg A; Leung KL; Fisch SC; Grogan TR; Abbott DH; Naik R; Chazenbalk GD
    Fertil Steril; 2021 Jul; 116(1):232-242. PubMed ID: 33341231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
    Sanchez-Garrido MA; Tena-Sempere M
    Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Body composition and polycystic ovary syndrome].
    Zabuliene L; Tutkuviene J
    Medicina (Kaunas); 2010; 46(2):142-57. PubMed ID: 20440089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovary syndrome.
    Goudas VT; Dumesic DA
    Endocrinol Metab Clin North Am; 1997 Dec; 26(4):893-912. PubMed ID: 9429864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran.
    Tehrani FR; Rashidi H; Khomami MB; Tohidi M; Azizi F
    Reprod Biol Endocrinol; 2014 Sep; 12():89. PubMed ID: 25224635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostics of polycystic ovary syndrome].
    Lazúrová I; Figurová J; Lazúrová Z
    Vnitr Lek; 2015 Dec; 61(12 Suppl 5):5S40-4. PubMed ID: 27124971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of obesity on reproduction in women with polycystic ovary syndrome.
    Pasquali R; Gambineri A; Pagotto U
    BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys.
    Abbott DH; Rayome BH; Dumesic DA; Lewis KC; Edwards AK; Wallen K; Wilson ME; Appt SE; Levine JE
    Hum Reprod; 2017 Apr; 32(4):923-936. PubMed ID: 28333238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women.
    Dumesic DA; Akopians AL; Madrigal VK; Ramirez E; Margolis DJ; Sarma MK; Thomas AM; Grogan TR; Haykal R; Schooler TA; Okeya BL; Abbott DH; Chazenbalk GD
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4178-4188. PubMed ID: 27571186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is foetal hyperexposure to androgens a cause of PCOS?
    Filippou P; Homburg R
    Hum Reprod Update; 2017 Jul; 23(4):421-432. PubMed ID: 28531286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index.
    Condorelli RA; Calogero AE; Di Mauro M; Mongioi' LM; Cannarella R; Rosta G; La Vignera S
    J Endocrinol Invest; 2018 Apr; 41(4):383-388. PubMed ID: 28942551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
    Ezeh U; Ezeh C; Pisarska MD; Azziz R
    Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS.
    Zheng SH; Li XL
    Gynecol Endocrinol; 2016; 32(3):177-83. PubMed ID: 26502288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.